240 Users Online
Dermacosmetics Market Segmented By Skin Care, Hair Care, Anti-aging, Hygiene, Sun Care, Cosmetics, Facial care Treatment with Dry Skin, Atopic Skin Eczema, Hyperpigmentation, Scar & Acne, Psoriasis, Deep Wrinkles Indication
The global dermacosmetics market was valued at US$ 17.5 Bn in 2021 and is estimated to progress at a value CAGR of 3.5% to account for revenue worth US$ 25.7 Bn by the end of 2032.
As studied by Persistence Market Research, dermacosmetic product sales accounted for 6.9% revenue share of the global cosmetics market in 2021.
Dermacosmetics Market Size (2022)
US$ 18.1 Bn
Projected Market Value (2032)
US$ 25.7 Bn
Global Market Growth Rate (2022-2032)
Market Share of Top 5 Countries
The global market for dermacosmetics recorded a historic CAGR of 5.1% from 2012 to 2021.
Skin problems are prevalent across the world. Skin conditions can range from very mild to quite severe, but unlike many other health problems, they are typically visible to the sufferer or both the sufferer and other people. Even modest skin conditions can negatively affect a person's confidence and sense of wellness. Thus, the high prevalence of skin diseases will demand better treatment options, thus driving the growth of the dermacosmetics market during the forecast period.
Greater emphasis is given to skin health, as well as the increasing competition among established and new entrants in the dermacosmetics market develops a novel position and increases the competition to develop the treatment of eczema/dry skin and anti-aging. Newer claims and positionings from established and emerging players worldwide have entered the dermacosmetics category as the narrative shifts to emphasize prevention, effectiveness, and general skin health. Consumers' top skin concerns continue to be aging, and thus, dermacosmetic manufacturers are more inclined toward innovative products that combat aging.
The main focus is the production of specific products that target hyperpigmentation and discoloration along with aging. Specific skin conditions, including rosacea, hyperpigmentation, and UV damage are being addressed through new product launches, while general advantages such as skin brightening and lightening of dark spots are being promoted.
Celebrity endorsements for leading companies’ products along with radio and TV advertisements tend to influence target customers’ buying propensity. As such, companies in the sector need to allocate a greater budget for sales, marketing, and advertisements, apart from R&D initiatives, to capture greater market share.
According to industry statistics, customers tend to get attracted to treatments that are nicely displayed on billboard hoardings, magazines, and other types of media channels. Promotional strategies such as these are expected to contribute to the uptake of dermacosmetic products among consumers.
Worldwide sales of dermacosmetics are expected to increase at a CAGR of 3.5% and reach a global market size of US$ 25.7 Bn by 2032.
Dermacosmetics, which keeps advancing in terms of quality, technology, and therapeutic positioning, continues to focus on the microbiome domain. Probiotics and prebiotics, which have historically been used as digestion aids, are now being used by dermacosmetic product manufacturers as a trending element for preventive skin health.
In the context of skincare, probiotics contain live, "good" bacteria to enhance the body's inherent capacities to maintain healthy, and intact skin, whereas prebiotics promote the growth of specific bacteria, which can include particular healthy strains of bacteria.
Prebiotics and probiotics are both considered to be the next great innovations in skin care and dermacosmetics, as well as providing new potential in related areas such as oral care and hair care. The prospects for the microbiome in dermacosmetics are the greatest in post-biotics, anti-aging products, and acne treatments.
The concept will become more acceptable through additional research using a customization approach with the formation of suitable strains. Larger advancements for the sector, nevertheless, depend on the constantly evolving regulatory requirements for microbiome goods.
Manufacturers are offering an expanded range of Rx-formulated products to increase the revenue base from topical acne treatment products. This is primarily happening due to customers rejecting the 'one size fits all' approach. For example, with regard to moisturizers, companies need to produce at least eight to 10 variants depending on skin types, weather conditions, the strength of active ingredients, etc. This could result in greater product customization and expansion of formulated products.
The American Academy of Dermatology (AAD) has noted that there is a significant lack of long-term product efficacy studies and data leading to discontinuation in product usage. Furthermore, this lack of data also creates an information gap between regional research forums due to bias arising from the skewed selection of the clinical trial population, differences in skin types, etc.
The lack of availability of long-term data hampers a company’s product R&D and continued product usage. This also tends to affect the depth of product penetration in developed markets where consumers/ patients tend to do their own research before investing in a treatment/product.
The significance of dermacosmetics is not well known. Lack of awareness can negatively impact the overall market. New users of dermacosmetic goods are more inclined to use them without seeking advice from a professional, which could be harmful to those who have certain skin types and conditions.
U.S. Market Driven by Increasing Prevalence of Skin Diseases
The U.S. accounted for 90.2% share of the North American dermacosmetics market in 2021.
In the U.S., a large base of the population, especially youngsters, suffer from various forms of skin disorders such as acne vulgaris, psoriasis, hyperpigmentation, etc. These disorders are characterized by leftover scars during the recovery and affect the appearance and confidence of these youngsters as well as the other age groups.
Thus, the demand for dermacosmetics has increased in the U.S. in consideration of dermacosmetic product approvals, thus promoting the value of the market in the country.
Online Promotion of Skin Care Products Raising Demand for Dermacosmetics in Germany
Germany held 23.4% share of the Europe dermacosmetics market in 2021.
Germany continues to be one of the largest manufacturers of dermacosmetics in Europe. This is the result of the growth of online media as an effective advertisement vehicle. Various blogs, social media platforms, and social websites act as suitable mediums for posting prejudiced reviews of products as well as for rating their popularity quotient.
Increasing penetration of e-Commerce and the Internet across the world, primarily in European countries, largely contributes to patients’ uptake of products in this industry, backed by informed decision-making. This strategy has been acting as a major driving factor for the increasing and consistent usage and purchase of dermacosmetic treatment products by end users, in turn helping companies expand their product portfolios.
Rapidly Rising Number of Dermatology Clinics in Japan
Japan held the largest market share of 45.5% of the East Asia dermacosmetics market at the end of 2021.
The rising number of dermatology clinics in Japan has been fueling the demand for prescription products for treating acne. Designing effective yet well-tolerated regimes offering simplified dosing suiting patient lifestyles is more likely to optimize adherence and outcomes.
The availability of well-trained dermatologists who can effectively involve patients in treatment designs is the critical factor expected to fuel revenue growth of the dermacosmetics market in Japan.
Rapid Urbanization in India – A Game Changer
India led the South Asia dermacosmetics market with a share of 35.5% in 2021.
India is one of the most heavily populated countries in the world and is undergoing rapid urbanization and economic transition. The fast development of many South Asian cities is a big challenge that is accompanied by environmental pollution.
The incidence of skin disorders is rising quickly. The global epidemiology map of allergy diseases and asthma and the trend of changes in the prevalence of these diseases has been published by the International Study of Asthma and Allergies in Childhood (ISAAC). Rapid urbanization in the region can affect the rural environment and can increase environmental pollution. This is likely to increase the prevalence of skin diseases and will drive the demand for dermacosmetics in the near future.
High Demand for Skin Care Treatment across Regions
The dermacosmetics skin care treatment segment held 25% share of the global market in 2021.
High demand for dermacosmetic products is being driven by an increase in the prevalence of skin conditions and skin cancer. People are more inclined to seek medical care for healthy-looking skin, and dermacosmetic products are also used in procedures such as skin lightening and laser treatments, thus accelerating segment growth.
Dermacosmetics Most Commonly Used for Acne & Scars as Therapeutics
Acne & scars held the largest market share of 24.8% in 2021 due to the increasing prevalence of acne, primarily within the age group of 18 to 30 years and onwards. This has led to people trying to improve their skincare regimens, thus, creating sufficient traction for product manufacturers.
To strengthen their product lines around the world, leading dermacosmetic product manufacturers are developing innovative solutions. Similarly, several major competitors in the dermacosmetics industry have engaged in consolidation activities to speed up research and development.
Many companies are focused on collaborations with other firms with products in advanced stages of development to enable quicker approval and distribution of their products.
Historical Data Available for
USD Million for Value
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon Request
By Distribution Channel:
The global dermacosmetics market was valued at US$ 17.5 Bn in 2021.
Sales of dermacosmetic products are set to increase at 3.5% CAGR and reach US$ 25.7 Bn by 2032.
Demand for dermacosmetics increased at 5.1% CAGR from 2012 to 2021.
The U.S., Japan, Germany, China, and Canada collectively account for 61.4% market share.
The U.S. accounts for 90.2% share of the North American market.
L’Oreal Group, Pierre Fabre Group, and BEIERSDORF are the top three manufacturers of dermacosmetic products.
China held a share of 41.3% in the East Asia dermacosmetics market in 2021, while Japan accounted for 45.5% share.